US Stock MarketDetailed Quotes

OTLK Outlook Therapeutics

Watchlist
  • 7.675
  • -0.325-4.06%
Trading May 9 12:11 ET
178.82MMarket Cap-1918P/E (TTM)

Outlook Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Outlook Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings Estimates

May 16, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.90

-50.84%
Analyst Rating

Strong Buy

Apr 30, 2024

Outlook Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
May 16, 20242024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 176.250K--
--2023/Q30.000 / 43.750K--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
May 16, 20242024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 176.250K--
--2023/Q30.000 / 43.750K--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Outlook Therapeutics Earnings Reports

  • Outlook Therapeutics | 10-Q: Quarterly report

    Feb 14 17:17 ET

  • Outlook Therapeutics | 10-K/A: Annual report (Amendment)

    Jan 24 17:05 ET

  • Outlook Therapeutics: FY2023 Annual Report

    Dec 22, 2023 17:00 ET

  • Outlook Therapeutics | 10-Q: Q3 2023 Earnings Report

    Aug 14, 2023 16:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg